Philips North America vs SQUARE PHARMS PLC: FDA Enforcement Comparison

Philips North America has been the subject of 23 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for SQUARE PHARMS PLC.

Philips North America: 0 warning letters, 23 recalls, 0 approval records, 0 Form 483s.

SQUARE PHARMS PLC: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Side by side

Philips North America — Warning letters0

SQUARE PHARMS PLC — Warning letters0

Philips North America — Recalls23

SQUARE PHARMS PLC — Recalls0

Philips North America — Approval records0

SQUARE PHARMS PLC — Approval records1

Philips North America — Form 483s0

SQUARE PHARMS PLC — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

SQUARE PHARMS PLC

Most recent FDA action: July 9, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs SQUARE PHARMS PLC: FDA Enforcement Comparison." Argus HQ, accessed July 16, 2026. https://argushq.ai/compare/philips-north-america-vs-square-pharms-plc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗